What is Exagen Inc.'s accrued liabilities, current?

Exagen Inc. (XGN) reported accrued liabilities, current of $4.77M in Q1 2026.

How has Exagen Inc.'s accrued liabilities, current changed year-over-year?

Exagen Inc.'s accrued liabilities, current decreased by 3.6% year-over-year, from $4.95M to $4.77M.

What is the long-term trend for Exagen Inc.'s accrued liabilities, current?

Over 5 years (2020 to 2025), Exagen Inc.'s accrued liabilities, current has grown at a 1.9% compound annual growth rate (CAGR), from $5.76M to $6.33M.

Exagen Inc. XGN Accrued Liabilities, Current

Accrued Liabilities, Current at other companies

Idexx LaboratoriesIDXX

$453.55M-7.6%

Labcorp HoldingsLH

——

Vor BiopharmaVOR

——

RevvityRVTY

——

Biodesix, Inc.BDSX

——

Janux TherapeuticsJANX

——

Other financials

Income statement

See full

Revenue$17.3M+11.7%

Gross profit$10.2M+11.9%

Operating income-$3.4M-1.5%

Net income-$4.0M-5.7%

EPS (diluted)-$0.17+15.0%

Balance sheet

See full

Cash & equivalents$21.7M+90.6%

Total debt$27.1M+15.8%

Total equity$14.4M+125%

Total assets$52.0M+28.9%

Cash flow

See full

Operating cash flow-$10.4M+2.4%

CapEx$228.0K+102%

Free cash flow-$10.6M+1.3%

Valuation

See full

Market cap$112.34M-26.5%

Enterprise value$117.78M-20.3%

P/S1.6×-1.0×

Profitability

See full

Gross margin58.3%-1.0pp

Operating margin-20.6%-2.9pp

Net margin-29.5%+2.5pp

FCF margin-27.5%—

Returns & leverage

See full

Return on equity-193.6%+355pp

Debt / equity1.9×-1.8×

Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s accrued liabilities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Exagen Inc.'s accrued liabilities, current?: Exagen Inc. (XGN) reported accrued liabilities, current of $4.77M in Q1 2026.
How has Exagen Inc.'s accrued liabilities, current changed year-over-year?: Exagen Inc.'s accrued liabilities, current decreased by 3.6% year-over-year, from $4.95M to $4.77M.
What is the long-term trend for Exagen Inc.'s accrued liabilities, current?: Over 5 years (2020 to 2025), Exagen Inc.'s accrued liabilities, current has grown at a 1.9% compound annual growth rate (CAGR), from $5.76M to $6.33M.